Purpose of This Study is the Demonstration of Safety and Efficacy of the Dermal Fillers DXP01 Temporary Improvement of Moderate to Severe Nasolabial Folds
PHASE2Not yet recruitingINTERVENTIONAL
Enrollment
80
Participants
Timeline
Start Date
April 28, 2025
Primary Completion Date
April 1, 2027
Study Completion Date
December 1, 2027
Conditions
Dermal FillersNasolabial Folds, Wrinkles
Interventions
DEVICE
DXP01
PCL Dermal Filler
DEVICE
Juvederm ULTRA 3
HA Dermal filler
Trial Locations (1)
10 Cozia Street, Building A,
Societatea Civila Medicala Dr. Rosu, Romania
All Listed Sponsors
lead
DEXLEVO
INDUSTRY
NCT06885775 - Purpose of This Study is the Demonstration of Safety and Efficacy of the Dermal Fillers DXP01 Temporary Improvement of Moderate to Severe Nasolabial Folds | Biotech Hunter | Biotech Hunter